Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis

Clinical trial NCT05122559 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05122559
Sponsor: Emmanuelle Waubant, MD PhD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive

Start date: 2022-02-16
Primary completion: 2027-02-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.